Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.4895589942428015e-63,95.11750972762646,13711.260867074572,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.0754894855128903e-60,0,0,78
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,4.516008238492629e-40,34.17381316998468,3096.0030973556154,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'UCP3', 'COX11', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",9.75457779514408e-38,0,0,57
3,Oxidative phosphorylation WP623,3.74161512943073e-22,28.249436513899322,1393.7524686516203,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",5.387925786380252e-20,0,0,32
4,Mitochondrial complex I assembly model OXPHOS system WP4324,2.2479321804249555e-18,21.903620474406992,890.0869314384961,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'TMEM126B']",2.427766754858952e-16,0,0,28
5,Nonalcoholic fatty liver disease WP4396,1.495964513391582e-17,6.117639990386926,237.00456404003216,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.2925133395703268e-15,0,0,49
6,Mitochondrial CIV Assembly WP4922,1.374913266182615e-16,38.56972408650261,1408.680908037789,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",9.899375516514828e-15,0,0,22
7,Cellular Proteostasis WP4918,4.066549612107664e-06,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.0002509642046329301,0,0,6
8,Mitochondrial complex III assembly WP4921,7.46770878547147e-06,18.509225092250922,218.4999645660001,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0004032562744154594,0,0,8
9,Pyrimidine metabolism WP4022,0.0011833912700577075,2.8968842729970326,19.523177873550477,"['POLR3GL', 'NME2', 'NME3', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'TK1', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'POLR2L']",0.05680278096276996,0,0,15
10,mRNA Processing WP411,0.0027112346858040757,2.6060830860534123,15.402866149610594,"['DHX8', 'CELF1', 'NCBP2', 'CELF2', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.1094757118988292,0,0,15
11,Proteasome Degradation WP183,0.0027875759974238913,3.4693274205469327,20.408606085469163,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMB8']",0.1094757118988292,0,0,10
12,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0030984139799134923,13.842531272994849,79.96643328445288,"['COX8A', 'CYP2C8', 'GSTP1', 'COX5A']",0.11154290327688572,0,0,4
13,Sleep regulation WP3591,0.009557169937947394,3.2614716735402647,15.167355389399665,"['CACNA1I', 'AHCY', 'STAR', 'IL18', 'CRH', 'DRD1', 'BTBD9', 'HCRTR1']",0.31759210870717497,0,0,8
14,Base Excision Repair WP4752,0.014559868365162671,3.7771822871307026,15.975540649557276,"['POLE4', 'POLD4', 'NTHL1', 'TDG', 'APEX1', 'POLE3']",0.4492759381250196,0,0,6
15,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.028550063811580303,4.612214863870493,16.40147932575175,"['RRAS2', 'MAPK1', 'BRAF', 'HRAS']",0.7127037478716777,0,0,4
16,Cytosine methylation WP3585,0.030074601189421814,6.915441176470588,24.232219545721733,"['TDG', 'TET3', 'IDH2']",0.7127037478716777,0,0,3
17,Dual hijack model of Vif in HIV infection WP3300,0.030074601189421814,6.915441176470588,24.232219545721733,"['ELOB', 'ELOC', 'RUNX1']",0.7127037478716777,0,0,3
18,Purine metabolism WP4792,0.030074601189421814,6.915441176470588,24.232219545721733,"['PNP', 'ITPA', 'APRT']",0.7127037478716777,0,0,3
19,Nucleotide Excision Repair WP4753,0.03134576668880064,2.692969518190757,9.324881067137055,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.7127037478716777,0,0,7
20,Heme Biosynthesis WP561,0.04396378518384843,13.82365907421014,43.19048901433976,"['UROD', 'HMBS']",0.9043978666391678,0,0,2
21,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.04396378518384843,13.82365907421014,43.19048901433976,"['ELOB', 'ELOC']",0.9043978666391678,0,0,2
22,Cytosolic DNA-sensing pathway WP4655,0.04932185719266622,2.2159114391143913,6.668537172989982,"['RNF125', 'POLR3GL', 'TRADD', 'IL18', 'IKBKE', 'POLR2K', 'POLR2L', 'NFKBIB']",0.9119361742275711,0,0,8
23,Ciliary landscape WP4352,0.049473360823123015,1.542629878200348,4.637640473817411,"['RALB', 'DYNLT1', 'NDUFA5', 'SSNA1', 'EXOC6B', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'EHBP1', 'PSMD8', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'TMED1', 'EXOC6', 'DYNLRB2', 'SNRPB2', 'DCAF11', 'GLA']",0.9119361742275711,0,0,22
24,BDNF-TrkB Signaling WP3676,0.05066312079042062,2.595431098010317,7.741021276731325,"['NTRK2', 'TRPC6', 'DLG4', 'MAPK1', 'BRAF', 'HRAS']",0.9119361742275711,0,0,6
25,DNA Repair Pathways Full Network WP4946,0.063131397316512,1.7690914531395183,4.887180689255334,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'NTHL1', 'RFC2', 'TDG', 'APEX1', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.9998847516761723,0,0,12
26,Macrophage markers WP4146,0.06937071042279652,4.1483823529411765,11.069089391023253,"['CD163', 'CD14', 'CD68']",0.9998847516761723,0,0,3
27,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.06937071042279652,4.1483823529411765,11.069089391023253,"['EIF2S2', 'EIF3D', 'EIF1']",0.9998847516761723,0,0,3
28,DNA Mismatch Repair WP531,0.0714603252070761,3.0738287956831005,8.110644237373801,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.9998847516761723,0,0,4
29,Intraflagellar transport proteins binding to dynein WP4532,0.0714603252070761,3.0738287956831005,8.110644237373801,"['IFT22', 'DYNLT1', 'DYNLRB2', 'DYNLL1']",0.9998847516761723,0,0,4
30,Pilocytic astrocytoma WP2253,0.08060412009442672,6.911094783247612,17.403556983895697,"['NF1', 'BRAF']",0.9998847516761723,0,0,2
31,Eukaryotic Transcription Initiation WP405,0.09880371890052778,2.3055964653902796,5.3365797696724355,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2J', 'POLR2K']",0.9998847516761723,0,0,5
32,Selenium Micronutrient Network WP15,0.09899775235398763,1.6558721378955492,3.8294661662504694,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOS', 'ALOX5', 'ALOX5AP', 'DIO2', 'SELENOW', 'TXN', 'SELENOK', 'SELENOH']",0.9998847516761723,0,0,11
33,Peroxiredoxin 2 induced ovarian failure WP4873,0.12328257691602781,4.6069066862601025,9.643528053952247,"['STAR', 'BAX']",0.9998847516761723,0,0,2
34,Mitochondrial CII Assembly WP4920,0.126543238577733,inf,inf,['SDHAF1'],0.9998847516761723,0,0,1
35,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13446461039695107,2.3046357615894038,4.624146182331646,"['H2AFJ', 'H2AFZ', 'MAPK1', 'HIST1H3E']",0.9998847516761723,0,0,4
36,ERK Pathway in Huntington's Disease WP3853,0.1537335115097562,2.5919117647058822,4.853444512069232,"['NTRK2', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,3
37,Fatty acid transporters WP5061,0.1537335115097562,2.5919117647058822,4.853444512069232,"['FABP6', 'FABP7', 'DBI']",0.9998847516761723,0,0,3
38,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1537335115097562,2.5919117647058822,4.853444512069232,"['ZAP70', 'CD4', 'HLA-DRB1']",0.9998847516761723,0,0,3
39,Purine metabolism and related disorders WP4224,0.1537335115097562,2.5919117647058822,4.853444512069232,"['PNP', 'ITPA', 'APRT']",0.9998847516761723,0,0,3
40,Modulators of TCR signaling and T cell activation WP5072,0.16250231747197474,1.6695402298850575,3.0336598053615242,"['ZAP70', 'FIBP', 'NDUFB10', 'TNFAIP3', 'RHOH', 'ELOB', 'RNF7']",0.9998847516761723,0,0,7
41,IL-18 signaling pathway WP4754,0.1630727284202065,1.2792095134141437,2.319921914501701,"['NRN1', 'TOMM40', 'IMP3', 'CD81', 'NCF2', 'COX17', 'IL18', 'TNFAIP3', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'GATA1', 'GRM7', 'RASA3', 'NACA', 'TMSB4X', 'CYCS', 'MAPK1', 'BAX', 'PTPN7', 'RPS11', 'NOX1', 'ITM2C']",0.9998847516761723,0,0,24
42,TCA cycle in senescence WP5050,0.1698865876718689,3.454812637766348,6.124084474022861,"['ME1', 'BRAF']",0.9998847516761723,0,0,2
43,CAMKK2  Pathway WP4874,0.17906336196832023,1.8194326021238663,3.129452382931266,"['CHRM3', 'FIS1', 'MAP1LC3A', 'STIM1', 'MAPK1']",0.9998847516761723,0,0,5
44,MET in type 1 papillary renal cell carcinoma WP4205,0.17998222855134538,1.6137168141592921,2.7673583868686253,"['RPL11', 'MAPK1', 'BRAF', 'HRAS', 'PTK2', 'CRKL', 'PAK4']",0.9998847516761723,0,0,7
45,Corticotropin-releasing hormone signaling pathway WP2355,0.20543960283619436,1.4476486551475387,2.291053382121961,"['POMC', 'STAR', 'IL18', 'CRH', 'MAPK1', 'FOSB', 'BRAF', 'ACACA', 'PTK2']",0.9998847516761723,0,0,9
46,TNF-alpha signaling pathway WP231,0.2068838814852587,1.4116777531411677,2.2242360828175602,"['TRADD', 'TNFAIP3', 'MAPK1', 'BAX', 'CYBA', 'TXN', 'BTRC', 'HRAS', 'NOX1', 'NFKBIB']",0.9998847516761723,0,0,10
47,Microglia Pathogen Phagocytosis Pathway WP3937,0.21160419439913242,1.5954877841392212,2.4778527694286643,"['NCF2', 'ARPC1B', 'NCF4', 'ITGB2', 'RAC3', 'CYBA']",0.9998847516761723,0,0,6
48,Regulation of Actin Cytoskeleton WP51,0.21820994805782318,1.3090377256426182,1.9927450078958975,"['CHRM3', 'CHRM5', 'BRK1', 'RRAS2', 'BRAF', 'ARHGAP35', 'PTK2', 'SSH1', 'FGF17', 'TMSB4X', 'RAC3', 'MAPK1', 'CD14', 'PAK4']",0.9998847516761723,0,0,14
49,Iron metabolism in placenta WP2007,0.21874093459078478,2.7635562086700953,4.200238427169318,"['HEPHL1', 'FTH1']",0.9998847516761723,0,0,2
50,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.21874093459078478,2.7635562086700953,4.200238427169318,"['MAPK1', 'PTK2']",0.9998847516761723,0,0,2
51,Nanoparticle triggered regulated necrosis WP2513,0.21874093459078478,2.7635562086700953,4.200238427169318,"['TRADD', 'FTL']",0.9998847516761723,0,0,2
52,Kallmann's Syndrome WP5074,0.22129397508673174,2.073088235294118,3.1267628146207413,"['MAPK1', 'GNRH1', 'FRS2']",0.9998847516761723,0,0,3
53,Nanomaterial induced apoptosis WP2507,0.22129397508673174,2.073088235294118,3.1267628146207413,"['ENDOG', 'BAX', 'CYCS']",0.9998847516761723,0,0,3
54,Overview of nanoparticle effects WP3287,0.22129397508673174,2.073088235294118,3.1267628146207413,"['COL4A1', 'BAX', 'PTK2']",0.9998847516761723,0,0,3
55,Nephrotic syndrome WP4758,0.2260711169565259,1.64580265095729,2.4471532644621,"['TRPC6', 'TTC21B', 'PTPRO', 'E2F3', 'PAX2']",0.9998847516761723,0,0,5
56,SARS-CoV-2 mitochondrial interactions WP5038,0.24147036911830372,1.7277409860191317,2.4551346417546873,"['NDUFB9', 'PHB', 'IKBKE', 'NOX1']",0.9998847516761723,0,0,4
57,Cancer immunotherapy by PD-1 blockade WP4585,0.2569918136261181,1.8844251336898397,2.560389248629654,"['ZAP70', 'HLA-DRB1', 'BATF']",0.9998847516761723,0,0,3
58,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.2685310115971108,2.302718589272594,3.0275887771499064,"['HSD11B2', 'STAR']",0.9998847516761723,0,0,2
59,7q11.23 copy number variation syndrome WP4932,0.27041736849939846,1.3045782258851748,1.7061126676362288,"['RFC2', 'ATP5MC2', 'FZD9', 'ATP5PO', 'ATP5MC3', 'VPS37B', 'ATP5F1D', 'ACACA', 'ATP5F1E', 'ATP5MC1']",0.9998847516761723,0,0,10
60,Ferroptosis WP4313,0.2761887147458711,1.502369213037075,1.9330547442190469,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.9998847516761723,0,0,5
61,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.2761887147458711,1.502369213037075,1.9330547442190469,"['NTRK2', 'DLG4', 'NF1', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,5
62,TP53 network WP1742,0.29337383291459984,1.7272058823529413,2.1180857053963082,"['SUMO1', 'GADD45A', 'BAX']",0.9998847516761723,0,0,3
63,MAPK Cascade WP422,0.3006834269156667,1.5354427274957076,1.845137388410781,"['RASA3', 'MAPK1', 'BRAF', 'HRAS']",0.9998847516761723,0,0,4
64,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3182384837153267,1.9735488611315208,2.259623113669755,"['MAPK1', 'PTK2']",0.9998847516761723,0,0,2
65,RalA downstream regulated genes WP2290,0.3182384837153267,1.9735488611315208,2.259623113669755,"['RAC3', 'HRAS']",0.9998847516761723,0,0,2
66,Serotonin and anxiety WP3947,0.3182384837153267,1.9735488611315208,2.259623113669755,"['POMC', 'CRH']",0.9998847516761723,0,0,2
67,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.3182384837153267,1.9735488611315208,2.259623113669755,"['IDH2', 'IDH3B']",0.9998847516761723,0,0,2
68,Signaling of Hepatocyte Growth Factor Receptor WP313,0.33091492202022366,1.4544750396963713,1.608495175647073,"['MAPK1', 'HRAS', 'PTK2', 'CRKL']",0.9998847516761723,0,0,4
69,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.33364353668845104,3.4530102790014685,3.790307613573951,['MAP1LC3A'],0.9998847516761723,0,0,1
70,Mevalonate pathway WP3963,0.33364353668845104,3.4530102790014685,3.790307613573951,['PMVK'],0.9998847516761723,0,0,1
71,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.33364353668845104,3.4530102790014685,3.790307613573951,['CTDSP1'],0.9998847516761723,0,0,1
72,Mitochondrial fatty acid synthesis pathway WP4317,0.33364353668845104,3.4530102790014685,3.790307613573951,['ACACA'],0.9998847516761723,0,0,1
73,The alternative pathway of fetal androgen synthesis WP4524,0.33364353668845104,3.4530102790014685,3.790307613573951,['STAR'],0.9998847516761723,0,0,1
74,Kit receptor signaling pathway WP304,0.34778026238643694,1.2955047899778924,1.368291986309294,"['DOK1', 'RPS6', 'GRB10', 'MAPK1', 'HRAS', 'CRKL']",0.9998847516761723,0,0,6
75,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.35467309435119976,1.328594086326045,1.377165858251863,"['RNF125', 'TRADD', 'PIN1', 'IKBKE', 'NFKBIB']",0.9998847516761723,0,0,5
76,Amyotrophic lateral sclerosis (ALS) WP2447,0.3612852274440518,1.3816041206769683,1.4065939251294424,"['TOMM40', 'SLC1A2', 'BAX', 'NEFH']",0.9998847516761723,0,0,4
77,Copper homeostasis WP3286,0.3612852274440518,1.3816041206769683,1.4065939251294424,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.9998847516761723,0,0,4
78,Melanoma WP4685,0.36259890720855936,1.2401293396868618,1.258059122774545,"['GADD45A', 'NF1', 'MAPK1', 'BAX', 'E2F3', 'BRAF', 'HRAS']",0.9998847516761723,0,0,7
79,Type 2 papillary renal cell carcinoma WP4241,0.36665565344313206,1.4801470588235295,1.4850791240059202,"['SETD2', 'ELOB', 'ELOC']",0.9998847516761723,0,0,3
80,Cytokines and Inflammatory Response WP530,0.367087438528212,1.7266715650257163,1.7303928999881515,"['CD4', 'HLA-DRB1']",0.9998847516761723,0,0,2
81,"GPCRs, Class B Secretin-like WP334",0.367087438528212,1.7266715650257163,1.7303928999881515,"['ADGRE1', 'ADGRL2']",0.9998847516761723,0,0,2
82,LTF danger signal response pathway WP4478,0.367087438528212,1.7266715650257163,1.7303928999881515,"['MAPK1', 'CD14']",0.9998847516761723,0,0,2
83,Methionine De Novo and Salvage Pathway WP3580,0.367087438528212,1.7266715650257163,1.7303928999881515,"['AHCY', 'TXN']",0.9998847516761723,0,0,2
84,Alpha 6 Beta 4 signaling pathway WP244,0.39160507019454344,1.315673289183223,1.2334455782181584,"['LAMA5', 'MAPK1', 'HRAS', 'PTK2']",0.9998847516761723,0,0,4
85,Bladder cancer WP2828,0.39160507019454344,1.315673289183223,1.2334455782181584,"['DAPK1', 'MAPK1', 'BRAF', 'HRAS']",0.9998847516761723,0,0,4
86,Gastric Cancer Network 2 WP2363,0.4029002656498297,1.3813235294117647,1.25571456975746,"['AHCTF1', 'S100A6', 'COL9A3']",0.9998847516761723,0,0,3
87,Glycosylation and related congenital defects WP4521,0.4029002656498297,1.3813235294117647,1.25571456975746,"['DPM2', 'DPM3', 'MPDU1']",0.9998847516761723,0,0,3
88,Nanoparticle-mediated activation of receptor signaling WP2643,0.4029002656498297,1.3813235294117647,1.25571456975746,"['MAPK1', 'HRAS', 'PTK2']",0.9998847516761723,0,0,3
89,Parkinson's disease pathway WP2371,0.4029002656498297,1.3813235294117647,1.25571456975746,"['ATXN2', 'CYCS', 'PARK7']",0.9998847516761723,0,0,3
90,Photodynamic therapy-induced unfolded protein response WP3613,0.4029002656498297,1.3813235294117647,1.25571456975746,"['NARS', 'XBP1', 'DDIT3']",0.9998847516761723,0,0,3
91,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4029002656498297,1.3813235294117647,1.25571456975746,"['MAPK1', 'BRAF', 'HRAS']",0.9998847516761723,0,0,3
92,VEGFA-VEGFR2 Signaling Pathway WP3888,0.40580028966233145,1.0568727173005248,0.9531873081182793,"['RPL5', 'SET', 'NCF2', 'TXN', 'RPL10A', 'HDAC9', 'ACACA', 'RPL7', 'PNP', 'RPL18A', 'TMSB4X', 'FAM120A', 'GRB10', 'RPLP2', 'MAPK1', 'ELOC', 'RPS11', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'IDH2', 'SARS', 'RPL13A', 'FRS2', 'PTK2', 'DOK1', 'CYP2C8', 'RHOJ', 'CYCS', 'RPL27', 'RPL26', 'ALDOA', 'EIF3D', 'PTMA']",0.9998847516761723,0,0,37
93,Genotoxicity pathway WP4286,0.40761750733937013,1.2334315169366716,1.1069135449581757,"['AMER1', 'RPS27', 'GADD45A', 'RAPGEF2', 'TRIAP1']",0.9998847516761723,0,0,5
94,p53 transcriptional gene network WP4963,0.40761750733937013,1.2334315169366716,1.1069135449581757,"['SIVA1', 'NCF2', 'GADD45A', 'BAX', 'TNFRSF10D']",0.9998847516761723,0,0,5
95,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.41449940708043775,1.5346558902767573,1.3515464811632059,"['RPS6', 'ACACA']",0.9998847516761723,0,0,2
96,"Degradation pathway of sphingolipids, including diseases WP4153",0.4179899798389396,2.301762114537445,2.007822071037156,['GLA'],0.9998847516761723,0,0,1
97,Metabolism of alpha-linolenic acid WP4586,0.4179899798389396,2.301762114537445,2.007822071037156,['ALOX5'],0.9998847516761723,0,0,1
98,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.42170214275718987,1.2557361696434544,1.084272976566193,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'DDIT3']",0.9998847516761723,0,0,4
99,IL-2 signaling pathway WP49,0.42170214275718987,1.2557361696434544,1.084272976566193,"['RPS6', 'MAPK1', 'HRAS', 'CRKL']",0.9998847516761723,0,0,4
100,Splicing factor NOVA regulated synaptic proteins WP4148,0.42170214275718987,1.2557361696434544,1.084272976566193,"['KCNQ2', 'GRIK2', 'ANK3', 'STX2']",0.9998847516761723,0,0,4
101,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.4279262194281762,1.15117994100295,0.9771266944026576,"['RALB', 'GADD45A', 'RAC3', 'MAPK1', 'CYCS', 'BAX', 'BRAF']",0.9998847516761723,0,0,7
102,Non-small cell lung cancer WP4255,0.4279262194281762,1.15117994100295,0.9771266944026576,"['GADD45A', 'MAPK1', 'CYCS', 'BAX', 'E2F3', 'BRAF', 'HRAS']",0.9998847516761723,0,0,7
103,Hematopoietic Stem Cell Differentiation WP2849,0.4339095298220338,1.1907724341069523,0.9941987957438652,"['RHOH', 'FOSB', 'ACVR1B', 'GATA1', 'RUNX1']",0.9998847516761723,0,0,5
104,Disruption of postsynaptic signaling by CNV WP4875,0.4385183578046901,1.2948529411764707,1.067416687467344,"['DLG2', 'MAPK1', 'DLGAP1']",0.9998847516761723,0,0,3
105,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4385183578046901,1.2948529411764707,1.067416687467344,"['MAP1LC3A', 'ACACA', 'FTL']",0.9998847516761723,0,0,3
106,Integrin-mediated Cell Adhesion WP185,0.44090258425476353,1.1100443131462334,0.9090500605267757,"['SHC3', 'ITGB2', 'RAC3', 'MAPK1', 'BRAF', 'ITGAE', 'HRAS', 'PTK2', 'PAK4']",0.9998847516761723,0,0,9
107,Acute viral myocarditis WP4298,0.44958820176525793,1.1242882623310695,0.8987821455480453,"['CD4', 'ENDOG', 'ITGB2', 'RAC3', 'MAPK1', 'CYCS', 'BAX']",0.9998847516761723,0,0,7
108,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4551246905721627,1.1050036900369005,0.8698410615965586,"['SHC3', 'RPS6', 'NF1', 'RRAS2', 'MAPK1', 'BAX', 'BRAF', 'HRAS']",0.9998847516761723,0,0,8
109,ErbB signaling pathway WP673,0.4551246905721627,1.1050036900369005,0.8698410615965586,"['SHC3', 'NRG3', 'MAPK1', 'BRAF', 'HRAS', 'PTK2', 'CRKL', 'PAK4']",0.9998847516761723,0,0,8
110,Complement system WP2806,0.4597530918495354,1.0904532379693694,0.8473537982697686,"['LAMA5', 'FKBP2', 'FCGR3A', 'RPS19', 'ITGB2', 'F11', 'CD59', 'VSIG4', 'TXN']",0.9998847516761723,0,0,9
111,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.46005587452619784,1.38104335047759,1.0722521810686068,"['MAPK1', 'BRAF']",0.9998847516761723,0,0,2
112,NO/cGMP/PKG mediated Neuroprotection WP4008,0.480627309294018,1.1508462104488595,0.8431825912543512,"['DLG4', 'CYCS', 'CNGA3', 'CNGB1']",0.9998847516761723,0,0,4
113,Biotin Metabolism (including IEMs) WP5031,0.4916667935175499,1.7261380323054332,1.22547867114251,['ACACA'],0.9998847516761723,0,0,1
114,"Cerebral organic acidurias, including diseases WP4519",0.4916667935175499,1.7261380323054332,1.22547867114251,['IDH2'],0.9998847516761723,0,0,1
115,FTO Obesity Variant Mechanism WP3407,0.4916667935175499,1.7261380323054332,1.22547867114251,['FTO'],0.9998847516761723,0,0,1
116,MED and Pseudoachondroplasia genes WP4789,0.4916667935175499,1.7261380323054332,1.22547867114251,['COL9A3'],0.9998847516761723,0,0,1
117,Metastatic brain tumor WP2249,0.4916667935175499,1.7261380323054332,1.22547867114251,['E2F3'],0.9998847516761723,0,0,1
118,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.4916667935175499,1.7261380323054332,1.22547867114251,['PMVK'],0.9998847516761723,0,0,1
119,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.4916667935175499,1.7261380323054332,1.22547867114251,['MAPK1'],0.9998847516761723,0,0,1
120,Trans-sulfuration pathway WP2333,0.4916667935175499,1.7261380323054332,1.22547867114251,['AHCY'],0.9998847516761723,0,0,1
121,Valproic acid pathway WP3871,0.4916667935175499,1.7261380323054332,1.22547867114251,['HSD17B10'],0.9998847516761723,0,0,1
122,22q11.2 copy number variation syndrome WP4657,0.49490098368789187,1.0622764689185353,0.7472026862431067,"['RANBP1', 'P2RX6', 'MRPL40', 'THAP7', 'LRRC74B', 'DGCR6L', 'CRKL', 'PAK4']",0.9998847516761723,0,0,8
123,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5034671070273697,1.2553603633691803,0.8614746011313325,"['MAPK1', 'HRAS']",0.9998847516761723,0,0,2
124,Type II diabetes mellitus WP1584,0.5034671070273697,1.2553603633691803,0.8614746011313325,"['SURF1', 'MAPK1']",0.9998847516761723,0,0,2
125,3q29 copy number variation syndrome WP4906,0.5108343247160836,1.0787923416789396,0.7246355597336568,"['DYNLT1', 'NCBP2', 'PIGM', 'DYNLRB2', 'DYNLL1']",0.9998847516761723,0,0,5
126,Prolactin Signaling Pathway WP2037,0.5341007267722009,1.0281648151634972,0.6448349814236375,"['ZAP70', 'RPS6', 'MAPK1', 'PPIB', 'HRAS', 'PTK2', 'NFKBIB']",0.9998847516761723,0,0,7
127,Ras signaling WP4223,0.5344129293423175,1.0052649016162023,0.629885379005124,"['NTRK2', 'SHC3', 'RALB', 'RRAS2', 'RASAL2', 'RASAL3', 'ZAP70', 'GNG10', 'GNG3', 'RASA3', 'NF1', 'RAC3', 'MAPK1', 'HRAS', 'PAK4']",0.9998847516761723,0,0,15
128,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5355394727908404,1.045990092381845,0.6532006039371261,"['PSMD8', 'PSMC5', 'PSMD7', 'PSMC1', 'STUB1']",0.9998847516761723,0,0,5
129,PPAR signaling pathway WP3942,0.5355394727908404,1.045990092381845,0.6532006039371261,"['FABP6', 'FABP7', 'ME1', 'DBI', 'CPT1B']",0.9998847516761723,0,0,5
130,Neural Crest Cell Migration in Cancer WP4565,0.537036853260946,1.062093168053433,0.660291170938938,"['NTRK2', 'TRIO', 'F2RL2', 'PAK4']",0.9998847516761723,0,0,4
131,Prion disease pathway WP3995,0.5396235300082503,1.0900541795665635,0.6724364911210009,"['MAPK1', 'PTK2', 'BATF']",0.9998847516761723,0,0,3
132,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5396235300082503,1.0900541795665635,0.6724364911210009,"['MAPK1', 'BAX', 'BRAF']",0.9998847516761723,0,0,3
133,Vitamin D-sensitive calcium signaling in depression WP4698,0.5396235300082503,1.0900541795665635,0.6724364911210009,"['GPX4', 'KCNQ2', 'PVALB']",0.9998847516761723,0,0,3
134,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5445462981142661,1.1506245407788391,0.6993522556086783,"['CD63', 'CD81']",0.9998847516761723,0,0,2
135,Bile acids synthesis and enterohepatic circulation  WP4389,0.5560227932716327,1.3807635829662261,0.8104336488213975,['MAPK1'],0.9998847516761723,0,0,1
136,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5560227932716327,1.3807635829662261,0.8104336488213975,['SST'],0.9998847516761723,0,0,1
137,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5560227932716327,1.3807635829662261,0.8104336488213975,['VEGFB'],0.9998847516761723,0,0,1
138,Non-homologous end joining WP438,0.5560227932716327,1.3807635829662261,0.8104336488213975,['DCLRE1C'],0.9998847516761723,0,0,1
139,Serotonin and anxiety-related events WP3944,0.5560227932716327,1.3807635829662261,0.8104336488213975,['CRH'],0.9998847516761723,0,0,1
140,Aryl Hydrocarbon Receptor Netpath WP2586,0.5640536902975845,1.0226473714332434,0.585573853514762,"['AIP', 'NF1', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,4
141,Translation Factors WP107,0.5640536902975845,1.0226473714332434,0.585573853514762,"['EEF1B2', 'EIF2S2', 'EIF3D', 'EIF1']",0.9998847516761723,0,0,4
142,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5831313108237202,0.9860088365243005,0.5317968505452357,"['TMSB4X', 'FZD9', 'MAPK1', 'NEFH', 'PTK2']",0.9998847516761723,0,0,5
143,Fatty Acid Biosynthesis WP357,0.5831881893709551,1.062001921663935,0.5726795978573237,"['ACAA2', 'ACACA']",0.9998847516761723,0,0,2
144,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5901802963081122,0.986019131714496,0.5199547096499034,"['NDUFA13', 'COPS6', 'ACAP1', 'IL18']",0.9998847516761723,0,0,4
145,Histone Modifications WP2369,0.6008790050651278,0.9860294117647059,0.5022456050045089,"['SETD2', 'SET', 'HIST1H3E']",0.9998847516761723,0,0,3
146,p38 MAPK Signaling Pathway WP400,0.6008790050651278,0.9860294117647059,0.5022456050045089,"['TRADD', 'DDIT3', 'HRAS']",0.9998847516761723,0,0,3
147,Pancreatic adenocarcinoma pathway WP4263,0.6077858867653453,0.9517750349917292,0.47391983583822933,"['RALB', 'GADD45A', 'RAC3', 'MAPK1', 'BAX', 'E2F3', 'BRAF', 'PAK4']",0.9998847516761723,0,0,8
148,Codeine and Morphine Metabolism WP1604,0.6122363923783204,1.1505139500734214,0.5644844931667784,['CYP2C8'],0.9998847516761723,0,0,1
149,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6122363923783204,1.1505139500734214,0.5644844931667784,['CYP2C8'],0.9998847516761723,0,0,1
150,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6122363923783204,1.1505139500734214,0.5644844931667784,['RPS6'],0.9998847516761723,0,0,1
151,Insulin signaling in adipocytes (normal condition) WP3634,0.6122363923783204,1.1505139500734214,0.5644844931667784,['RPS6'],0.9998847516761723,0,0,1
152,Leptin and adiponectin WP3934,0.6122363923783204,1.1505139500734214,0.5644844931667784,['ACACA'],0.9998847516761723,0,0,1
153,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6122363923783204,1.1505139500734214,0.5644844931667784,['AHCY'],0.9998847516761723,0,0,1
154,Nanomaterial-induced inflammasome activation WP3890,0.6122363923783204,1.1505139500734214,0.5644844931667784,['NOX1'],0.9998847516761723,0,0,1
155,Osteoclast Signaling WP12,0.6122363923783204,1.1505139500734214,0.5644844931667784,['TNFRSF11B'],0.9998847516761723,0,0,1
156,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6129527494448519,0.9471195557869165,0.4635841718971359,"['POMC', 'RPS6KA6', 'RPS6', 'DIO2', 'MAPK1', 'FRS2', 'HRAS']",0.9998847516761723,0,0,7
157,Ebstein-Barr virus LMP1 signaling WP262,0.6193514472670348,0.9860396767083027,0.4723942560285915,"['TRADD', 'MAPK1']",0.9998847516761723,0,0,2
158,Eicosanoid Synthesis WP167,0.6193514472670348,0.9860396767083027,0.4723942560285915,"['ALOX5', 'ALOX5AP']",0.9998847516761723,0,0,2
159,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6193514472670348,0.9860396767083027,0.4723942560285915,"['RPS6', 'MAPK1']",0.9998847516761723,0,0,2
160,Leptin signaling pathway WP2034,0.6194687522974083,0.9409794332417767,0.4506284819624375,"['RPS6', 'MAPK1', 'BAX', 'HRAS', 'ACACA', 'PTK2']",0.9998847516761723,0,0,6
161,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6279618774982081,0.9325120407594635,0.4338753034704839,"['LAMA5', 'TRPC6', 'PTPRO', 'PAX2', 'PTK2']",0.9998847516761723,0,0,5
162,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6279618774982081,0.9325120407594635,0.4338753034704839,"['APEX1', 'RPS6', 'MAPK1', 'BRAF', 'HRAS']",0.9998847516761723,0,0,5
163,Circadian rhythm related genes WP3594,0.6310549790716139,0.9375517283568555,0.4316134608197461,"['KDM5A', 'AHCY', 'KCNH7', 'CAVIN3', 'BTBD9', 'CIART', 'HCRTR1', 'STAR', 'CRH', 'AVP', 'DRD1', 'BTRC', 'RPS27A', 'UBA52']",0.9998847516761723,0,0,14
164,Angiogenesis WP1539,0.6530441901100209,0.9202057310800882,0.3921093053507052,"['MAPK1', 'PTK2']",0.9998847516761723,0,0,2
165,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6530441901100209,0.9202057310800882,0.3921093053507052,"['GRB10', 'HRAS']",0.9998847516761723,0,0,2
166,Small cell lung cancer WP4658,0.6590638967310894,0.9046760631540741,0.37719092354225253,"['LAMA5', 'COL4A1', 'GADD45A', 'CYCS', 'BAX', 'E2F3', 'PTK2', 'NFKBIB']",0.9998847516761723,0,0,8
167,Biomarkers for pyrimidine metabolism disorders WP4584,0.6613371153704523,0.9860499265785609,0.40772332338033973,['NT5C'],0.9998847516761723,0,0,1
168,Cancer immunotherapy by CTLA4 blockade WP4582,0.6613371153704523,0.9860499265785609,0.40772332338033973,['HLA-DRB1'],0.9998847516761723,0,0,1
169,Genes targeted by miRNAs in adipocytes WP1992,0.6613371153704523,0.9860499265785609,0.40772332338033973,['TMSB4X'],0.9998847516761723,0,0,1
170,Homologous recombination WP186,0.6613371153704523,0.9860499265785609,0.40772332338033973,['POLD4'],0.9998847516761723,0,0,1
171,IL-9 signaling pathway WP22,0.6613371153704523,0.9860499265785609,0.40772332338033973,['MAPK1'],0.9998847516761723,0,0,1
172,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6613371153704523,0.9860499265785609,0.40772332338033973,['BAX'],0.9998847516761723,0,0,1
173,Osteoblast Signaling WP322,0.6613371153704523,0.9860499265785609,0.40772332338033973,['TNFRSF11B'],0.9998847516761723,0,0,1
174,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6613371153704523,0.9860499265785609,0.40772332338033973,['DLL3'],0.9998847516761723,0,0,1
175,Interleukin-11 Signaling Pathway WP2332,0.6821454039689712,0.8625,0.3299169808476661,"['RPS6', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,3
176,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6821454039689712,0.8625,0.3299169808476661,"['STAR', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,3
177,Monoamine GPCRs WP58,0.6821454039689712,0.8625,0.3299169808476661,"['CHRM3', 'CHRM5', 'DRD1']",0.9998847516761723,0,0,3
178,Regulation of Microtubule Cytoskeleton WP2038,0.6821454039689712,0.8625,0.3299169808476661,"['TRIO', 'PARD6A', 'F2RL2']",0.9998847516761723,0,0,3
179,Estrogen signaling pathway WP712,0.6843121497776482,0.8626010286554004,0.32722002836400615,"['MAPK1', 'BRAF']",0.9998847516761723,0,0,2
180,Unfolded protein response WP4925,0.6843121497776482,0.8626010286554004,0.32722002836400615,"['XBP1', 'DDIT3']",0.9998847516761723,0,0,2
181,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6848715219971238,0.8623988226637234,0.3264386669898634,"['BEX3', 'MAPK1', 'RNF7', 'PTK2']",0.9998847516761723,0,0,4
182,Netrin-UNC5B signaling pathway WP4747,0.6848715219971238,0.8623988226637234,0.3264386669898634,"['ARHGEF12', 'DAPK1', 'MAPK1', 'PTK2']",0.9998847516761723,0,0,4
183,Endometrial cancer WP4155,0.6894387320840487,0.8622974963181149,0.32066898904343033,"['GADD45A', 'MAPK1', 'BAX', 'BRAF', 'HRAS']",0.9998847516761723,0,0,5
184,Cholesterol Biosynthesis Pathway WP197,0.7042243974251454,0.8627019089574156,0.30251352205778165,['PMVK'],0.9998847516761723,0,0,1
185,Cysteine and methionine catabolism WP4504,0.7042243974251454,0.8627019089574156,0.30251352205778165,['AHCY'],0.9998847516761723,0,0,1
186,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7042243974251454,0.8627019089574156,0.30251352205778165,['MAPK1'],0.9998847516761723,0,0,1
187,Nanoparticle triggered autophagic cell death WP2509,0.7042243974251454,0.8627019089574156,0.30251352205778165,['MAP1LC3A'],0.9998847516761723,0,0,1
188,Nephrogenesis WP5052,0.7042243974251454,0.8627019089574156,0.30251352205778165,['PAX2'],0.9998847516761723,0,0,1
189,Osteopontin Signaling WP1434,0.7042243974251454,0.8627019089574156,0.30251352205778165,['MAPK1'],0.9998847516761723,0,0,1
190,Pyrimidine metabolism and related diseases WP4225,0.7042243974251454,0.8627019089574156,0.30251352205778165,['NT5C'],0.9998847516761723,0,0,1
191,Tamoxifen metabolism WP691,0.7042243974251454,0.8627019089574156,0.30251352205778165,['CYP2C8'],0.9998847516761723,0,0,1
192,Neural Crest Cell Migration during Development WP4564,0.7063275504117074,0.8279117647058823,0.28784521352055037,"['TRIO', 'F2RL2', 'PAK4']",0.9998847516761723,0,0,3
193,Wnt Signaling Pathway WP363,0.7063275504117074,0.8279117647058823,0.28784521352055037,"['RYK', 'MAPK1', 'CSNK1G1']",0.9998847516761723,0,0,3
194,Ethanol effects on histone modifications WP3996,0.7132290345410316,0.8117733500453819,0.274340982110449,"['AHCY', 'HDAC9']",0.9998847516761723,0,0,2
195,Fluoropyrimidine Activity WP1601,0.7132290345410316,0.8117733500453819,0.274340982110449,"['TDG', 'TK1']",0.9998847516761723,0,0,2
196,Imatinib and Chronic Myeloid Leukemia WP3640,0.7132290345410316,0.8117733500453819,0.274340982110449,"['GADD45A', 'SKP2']",0.9998847516761723,0,0,2
197,Sphingolipid pathway WP1422,0.7132290345410316,0.8117733500453819,0.274340982110449,"['CERS6', 'GBA2']",0.9998847516761723,0,0,2
198,B Cell Receptor Signaling Pathway WP23,0.7162539118407615,0.8468793665579879,0.28262104749199535,"['CD81', 'MAPK1', 'BRAF', 'E2F3', 'PIK3AP1', 'HRAS', 'CRKL']",0.9998847516761723,0,0,7
199,Vitamin D Receptor Pathway WP2877,0.7164710669092684,0.87074681522459,0.2903221510976857,"['LRRC25', 'COLEC11', 'CRACR2A', 'GADD45A', 'TNFSF4', 'ALOX5', 'S100A6', 'TNFAIP3', 'TNFRSF11B', 'CD14', 'HLA-DRB1', 'NOX1']",0.9998847516761723,0,0,12
200,Synaptic Vesicle Pathway WP2267,0.7260171853822593,0.8114963424663464,0.2598261917354978,"['SLC32A1', 'SLC17A6', 'PARK7', 'STX2']",0.9998847516761723,0,0,4
201,DNA Replication WP466,0.7290730570787268,0.7959841628959275,0.2515161396431631,"['POLD4', 'RFC2', 'UBA52']",0.9998847516761723,0,0,3
202,Cell migration and invasion through p75NTR WP4561,0.7398887258995064,0.7665931912809208,0.23094039558531704,"['NTRK2', 'TRIO']",0.9998847516761723,0,0,2
203,GABA receptor Signaling WP4159,0.7398887258995064,0.7665931912809208,0.23094039558531704,"['SLC32A1', 'GABRA4']",0.9998847516761723,0,0,2
204,Inflammatory Response Pathway WP453,0.7398887258995064,0.7665931912809208,0.23094039558531704,"['LAMA5', 'ZAP70']",0.9998847516761723,0,0,2
205,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7398887258995064,0.7665931912809208,0.23094039558531704,"['SUPT4H1', 'HDAC9']",0.9998847516761723,0,0,2
206,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7398887258995064,0.7665931912809208,0.23094039558531704,"['TNFRSF11B', 'PPIB']",0.9998847516761723,0,0,2
207,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7416840117004833,0.766764561918747,0.22913377741604424,['MAPK1'],0.9998847516761723,0,0,1
208,Computational Model of Aerobic Glycolysis WP4629,0.7416840117004833,0.766764561918747,0.22913377741604424,['ALDOA'],0.9998847516761723,0,0,1
209,Cori Cycle WP1946,0.7416840117004833,0.766764561918747,0.22913377741604424,['ALDOA'],0.9998847516761723,0,0,1
210,Glutathione metabolism WP100,0.7416840117004833,0.766764561918747,0.22913377741604424,['GPX4'],0.9998847516761723,0,0,1
211,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7416840117004833,0.766764561918747,0.22913377741604424,['BAX'],0.9998847516761723,0,0,1
212,Immune response to tuberculosis WP4197,0.7416840117004833,0.766764561918747,0.22913377741604424,['PSMB8'],0.9998847516761723,0,0,1
213,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7416840117004833,0.766764561918747,0.22913377741604424,['MAPK1'],0.9998847516761723,0,0,1
214,Nucleotide metabolism WP404,0.7416840117004833,0.766764561918747,0.22913377741604424,['NME2'],0.9998847516761723,0,0,1
215,Omega-9 FA synthesis WP4724,0.7416840117004833,0.766764561918747,0.22913377741604424,['ELOVL3'],0.9998847516761723,0,0,1
216,Alzheimer's disease WP2059,0.7436129468172523,0.801880330170908,0.23754470871081526,"['PSENEN', 'ATP5MD', 'MAPK1', 'CYCS', 'HSD17B10']",0.9998847516761723,0,0,5
217,Androgen receptor signaling pathway WP138,0.7594520783533641,0.7955331330423445,0.21889734977160932,"['SUMO1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'PTK2']",0.9998847516761723,0,0,6
218,Endothelin Pathways WP2197,0.7643989999576501,0.7261688387021926,0.19509642328181487,"['RIIAD1', 'MAPK1']",0.9998847516761723,0,0,2
219,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7643989999576501,0.7261688387021926,0.19509642328181487,"['NTRK2', 'GABRA4']",0.9998847516761723,0,0,2
220,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.770377149038966,0.7389705882352942,0.1927790113992714,"['ITGB2', 'MAP4K3', 'PAK4']",0.9998847516761723,0,0,3
221,Pre-implantation embryo WP3527,0.770377149038966,0.7389705882352942,0.1927790113992714,"['DDIT3', 'CELF3', 'FOSB']",0.9998847516761723,0,0,3
222,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.770377149038966,0.7389705882352942,0.1927790113992714,"['TNFSF4', 'RPS6', 'MAPK1']",0.9998847516761723,0,0,3
223,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7744024237368484,0.690014684287812,0.17641164734552173,['HIST1H3E'],0.9998847516761723,0,0,1
224,Galanin receptor pathway WP4970,0.7744024237368484,0.690014684287812,0.17641164734552173,['POMC'],0.9998847516761723,0,0,1
225,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.7744024237368484,0.690014684287812,0.17641164734552173,['GRM7'],0.9998847516761723,0,0,1
226,ID signaling pathway WP53,0.7744024237368484,0.690014684287812,0.17641164734552173,['PAX2'],0.9998847516761723,0,0,1
227,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7744024237368484,0.690014684287812,0.17641164734552173,['NRG3'],0.9998847516761723,0,0,1
228,MTHFR deficiency WP4288,0.7744024237368484,0.690014684287812,0.17641164734552173,['CYCS'],0.9998847516761723,0,0,1
229,NOTCH1 regulation of endothelial cell calcification WP3413,0.7744024237368484,0.690014684287812,0.17641164734552173,['DLL3'],0.9998847516761723,0,0,1
230,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7744024237368484,0.690014684287812,0.17641164734552173,['ANAPC11'],0.9998847516761723,0,0,1
231,SARS coronavirus and innate immunity WP4912,0.7744024237368484,0.690014684287812,0.17641164734552173,['IKBKE'],0.9998847516761723,0,0,1
232,EGF/EGFR signaling pathway WP437,0.7807627444920288,0.8149217407902272,0.2016800591385476,"['NDUFA13', 'ATXN2', 'RALB', 'GRB10', 'MAPK1', 'FOSB', 'BRAF', 'NEDD8', 'HRAS', 'PTK2', 'CRKL']",0.9998847516761723,0,0,11
233,Common Pathways Underlying Drug Addiction WP2636,0.7868765129038587,0.6897869213813372,0.16533085501775902,"['MAPK1', 'DRD1']",0.9998847516761723,0,0,2
234,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7868765129038587,0.6897869213813372,0.16533085501775902,"['DDIT3', 'MAPK1']",0.9998847516761723,0,0,2
235,Breast cancer pathway WP4262,0.7999111463612456,0.7918546270102199,0.17678520743634454,"['FGF17', 'SHC3', 'GADD45A', 'FZD9', 'MAPK1', 'BAX', 'BRAF', 'E2F3', 'HRAS', 'DLL3']",0.9998847516761723,0,0,10
236,Apoptosis Modulation by HSP70 WP384,0.8029793338739082,0.6272193298625016,0.13762841778957932,['CYCS'],0.9998847516761723,0,0,1
237,Cells and molecules involved in local acute inflammatory response  WP4493,0.8029793338739082,0.6272193298625016,0.13762841778957932,['ITGB2'],0.9998847516761723,0,0,1
238,Hypertrophy Model WP516,0.8029793338739082,0.6272193298625016,0.13762841778957932,['IL18'],0.9998847516761723,0,0,1
239,miR-509-3p alteration of YAP1/ECM axis WP3967,0.8029793338739082,0.6272193298625016,0.13762841778957932,['GPC6'],0.9998847516761723,0,0,1
240,PPAR-alpha pathway WP2878,0.8029793338739082,0.6272193298625016,0.13762841778957932,['DBI'],0.9998847516761723,0,0,1
241,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8029793338739082,0.6272193298625016,0.13762841778957932,['CD4'],0.9998847516761723,0,0,1
242,Transcriptional cascade regulating adipogenesis WP4211,0.8029793338739082,0.6272193298625016,0.13762841778957932,['DDIT3'],0.9998847516761723,0,0,1
243,T-cell receptor (TCR) signaling pathway WP69,0.8045319746013899,0.7333218437627299,0.15949351809199308,"['ZAP70', 'CD4', 'MAPK1', 'HRAS', 'CRKL']",0.9998847516761723,0,0,5
244,Exercise-induced Circadian Regulation WP410,0.8063838303934832,0.6895588235294118,0.1483899099265805,"['SUMO1', 'GSTP1', 'UCP3']",0.9998847516761723,0,0,3
245,Aryl Hydrocarbon Receptor Pathway WP2873,0.8074428318470576,0.65686994856723,0.14049333022922642,"['AIP', 'BAX']",0.9998847516761723,0,0,2
246,Heart Development WP1591,0.8074428318470576,0.65686994856723,0.14049333022922642,"['VEGFB', 'MAPK1']",0.9998847516761723,0,0,2
247,PDGF Pathway WP2526,0.8074428318470576,0.65686994856723,0.14049333022922642,"['MAPK1', 'HRAS']",0.9998847516761723,0,0,2
248,MECP2 and Associated Rett Syndrome WP3584,0.8110592859384133,0.7070809984717269,0.1480727487912091,"['SST', 'RPS6', 'TET3', 'NF1']",0.9998847516761723,0,0,4
249,Pathways in clear cell renal cell carcinoma WP4018,0.8134482970348563,0.7383935151068534,0.15245825818683156,"['SETD2', 'ME1', 'GRB10', 'CDH13', 'ALDOA', 'ACACA']",0.9998847516761723,0,0,6
250,NRF2 pathway WP2884,0.8206016553924723,0.7549916595056362,0.1492750496074987,"['SERPINA1', 'FTH1', 'GSTP1', 'ME1', 'TXN', 'SLC6A20', 'SLC5A3', 'FTL']",0.9998847516761723,0,0,8
251,TGF-beta Signaling Pathway WP366,0.8206016553924723,0.7549916595056362,0.1492750496074987,"['PARD6A', 'CITED1', 'SUMO1', 'NEDD4L', 'MAPK1', 'FOSB', 'BTRC', 'PTK2']",0.9998847516761723,0,0,8
252,Interferon type I signaling pathways WP585,0.8225285368426059,0.6672438330170778,0.13036082999964585,"['ZAP70', 'RPS6', 'CRKL']",0.9998847516761723,0,0,3
253,16p11.2 proximal deletion syndrome WP4949,0.8251906466708417,0.6893303899926416,0.1324485149801713,"['SPN', 'TMEM219', 'ALDOA', 'SEZ6L2']",0.9998847516761723,0,0,4
254,IL17 signaling pathway WP2112,0.8262213267507406,0.6269454278271325,0.11967923731655279,"['MAPK1', 'NFKBIB']",0.9998847516761723,0,0,2
255,Development and heterogeneity of the ILC family WP3893,0.827938637019909,0.5748898678414097,0.10854854166314788,['IL18'],0.9998847516761723,0,0,1
256,MAPK pathway in congenital thyroid cancer WP4928,0.827938637019909,0.5748898678414097,0.10854854166314788,['BRAF'],0.9998847516761723,0,0,1
257,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.827938637019909,0.5748898678414097,0.10854854166314788,['SCO2'],0.9998847516761723,0,0,1
258,Signal Transduction of S1P Receptor WP26,0.827938637019909,0.5748898678414097,0.10854854166314788,['MAPK1'],0.9998847516761723,0,0,1
259,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.827938637019909,0.5748898678414097,0.10854854166314788,['EXOC6'],0.9998847516761723,0,0,1
260,Sphingolipid Metabolism (general overview) WP4725,0.827938637019909,0.5748898678414097,0.10854854166314788,['CERS6'],0.9998847516761723,0,0,1
261,Sphingolipid Metabolism (integrated pathway) WP4726,0.827938637019909,0.5748898678414097,0.10854854166314788,['CERS6'],0.9998847516761723,0,0,1
262,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.827938637019909,0.5748898678414097,0.10854854166314788,['IKBKE'],0.9998847516761723,0,0,1
263,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.827938637019909,0.5748898678414097,0.10854854166314788,['ZAP70'],0.9998847516761723,0,0,1
264,Transcription co-factors SKI and SKIL protein partners WP4533,0.827938637019909,0.5748898678414097,0.10854854166314788,['NF1'],0.9998847516761723,0,0,1
265,Chemokine signaling pathway WP3929,0.8296876969986321,0.7559714666570595,0.14114434641806559,"['GNG10', 'GNG3', 'SHC3', 'MAPK1', 'BRAF', 'HRAS', 'PTK2', 'CRKL', 'NFKBIB']",0.9998847516761723,0,0,9
266,Hippo-Merlin Signaling Dysregulation WP4541,0.8308652504169258,0.7447092849306871,0.13798543393715493,"['NTRK2', 'ITGB2', 'CDH13', 'ITGAE', 'HRAS', 'CDH8', 'PTK2', 'PAK4']",0.9998847516761723,0,0,8
267,IL-3 signaling pathway WP286,0.837509507748189,0.6463235294117647,0.114607809273476,"['MAPK1', 'HRAS', 'CRKL']",0.9998847516761723,0,0,3
268,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8384347121756098,0.6724456648539995,0.11849740901922622,"['MAPK1', 'BAX', 'HRAS', 'PTK2']",0.9998847516761723,0,0,4
269,TYROBP causal network in microglia WP3945,0.8422228967499159,0.6891016200294551,0.11832603664346172,"['CD4', 'NCF2', 'ITGB2', 'IL18', 'SLC1A5']",0.9998847516761723,0,0,5
270,Notch Signaling WP268,0.8433347690518759,0.5996230393253043,0.102170539285056,"['DTX3', 'DLL3']",0.9998847516761723,0,0,2
271,Senescence and Autophagy in Cancer WP615,0.8473212600149281,0.7006232591833931,0.11607601391796518,"['GABARAPL2', 'MAP1LC3A', 'MAPK1', 'BRAF', 'HRAS', 'GABARAP']",0.9998847516761723,0,0,6
272,Blood Clotting Cascade WP272,0.8497379984305647,0.5306110922851011,0.08639792595552628,['F11'],0.9998847516761723,0,0,1
273,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8497379984305647,0.5306110922851011,0.08639792595552628,['BAX'],0.9998847516761723,0,0,1
274,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8497379984305647,0.5306110922851011,0.08639792595552628,['GSTP1'],0.9998847516761723,0,0,1
275,Physiological and pathological hypertrophy of the heart WP1528,0.8497379984305647,0.5306110922851011,0.08639792595552628,['MAPK1'],0.9998847516761723,0,0,1
276,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8497379984305647,0.5306110922851011,0.08639792595552628,['MAPK1'],0.9998847516761723,0,0,1
277,Cardiac Hypertrophic Response WP2795,0.8513856600532685,0.6266711229946524,0.10082515991462813,"['MAPK1', 'IKBKE', 'HDAC9']",0.9998847516761723,0,0,3
278,RANKL/RANK signaling pathway WP2018,0.8513856600532685,0.6266711229946524,0.10082515991462813,"['MAPK1', 'TNFRSF11B', 'PTK2']",0.9998847516761723,0,0,3
279,Focal Adhesion WP306,0.8540002156735622,0.7646913580246913,0.12068652091660047,"['LAMA5', 'SHC3', 'VEGFB', 'BRAF', 'MYL12A', 'PTK2', 'ARHGAP35', 'CRKL', 'COL4A1', 'RAC3', 'MAPK1', 'HRAS', 'PAK4']",0.9998847516761723,0,0,13
280,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8589035087981229,0.5745775165319618,0.08739248928893917,"['ITGB2', 'CD14']",0.9998847516761723,0,0,2
281,Toll-like Receptor Signaling related to MyD88 WP3858,0.8589035087981229,0.5745775165319618,0.08739248928893917,"['MAPK1', 'IKBKE']",0.9998847516761723,0,0,2
282,Thermogenesis WP4321,0.8638637874177493,0.6624561006004305,0.09694394239280973,"['RPS6KA6', 'RPS6', 'FRS2', 'CPT1B', 'HRAS']",0.9998847516761723,0,0,5
283,Apoptosis Modulation and Signaling WP1772,0.866989442177071,0.6775070369788709,0.09669954937099527,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'TNFRSF11B', 'TNFRSF10D']",0.9998847516761723,0,0,6
284,MAPK Signaling Pathway WP382,0.8684984790406847,0.7695941771665602,0.10850465556839944,"['NTRK2', 'GADD45A', 'RRAS2', 'BRAF', 'CRKL', 'FGF17', 'CACNA1I', 'DDIT3', 'NF1', 'RAC3', 'RAPGEF2', 'MAPK1', 'CD14', 'PTPN7', 'HRAS', 'MAP4K3']",0.9998847516761723,0,0,16
285,EPO Receptor Signaling WP581,0.8687772213961761,0.49265785609397944,0.0693014655794457,['MAPK1'],0.9998847516761723,0,0,1
286,FOXA2 pathway WP5066,0.8687772213961761,0.49265785609397944,0.0693014655794457,['ACACA'],0.9998847516761723,0,0,1
287,GDNF/RET signaling axis WP4830,0.8687772213961761,0.49265785609397944,0.0693014655794457,['PAX2'],0.9998847516761723,0,0,1
288,Hippo-Yap signaling pathway WP4537,0.8687772213961761,0.49265785609397944,0.0693014655794457,['MAP4K3'],0.9998847516761723,0,0,1
289,IL-7 signaling pathway WP205,0.8687772213961761,0.49265785609397944,0.0693014655794457,['MAPK1'],0.9998847516761723,0,0,1
290,One-carbon metabolism WP241,0.8687772213961761,0.49265785609397944,0.0693014655794457,['AHCY'],0.9998847516761723,0,0,1
291,Proteoglycan biosynthesis WP4784,0.8687772213961761,0.49265785609397944,0.0693014655794457,['EXT2'],0.9998847516761723,0,0,1
292,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8687772213961761,0.49265785609397944,0.0693014655794457,['BAX'],0.9998847516761723,0,0,1
293,Statin inhibition of cholesterol production WP430,0.8687772213961761,0.49265785609397944,0.0693014655794457,['APOC1'],0.9998847516761723,0,0,1
294,Trans-sulfuration and one-carbon metabolism WP2525,0.8687772213961761,0.49265785609397944,0.0693014655794457,['AHCY'],0.9998847516761723,0,0,1
295,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8730441219556969,0.5515356355620867,0.0748815430802106,"['ARHGDIB', 'CYCS']",0.9998847516761723,0,0,2
296,Oxidative Damage WP3941,0.8730441219556969,0.5515356355620867,0.0748815430802106,"['GADD45A', 'CYCS']",0.9998847516761723,0,0,2
297,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8730441219556969,0.5515356355620867,0.0748815430802106,"['MAPK1', 'NFKBIB']",0.9998847516761723,0,0,2
298,Integrated breast cancer pathway WP1984,0.8754334360120527,0.6972021112616189,0.09275309150774147,"['GADD45A', 'TRADD', 'NF1', 'MAPK1', 'BAX', 'BRAF', 'PHB', 'FAU']",0.9998847516761723,0,0,8
299,16p11.2 distal deletion syndrome WP4950,0.8854055574341162,0.45976505139500734,0.055957766225919664,['CD81'],0.9998847516761723,0,0,1
300,Cannabinoid receptor signaling WP3869,0.8854055574341162,0.45976505139500734,0.055957766225919664,['MAPK1'],0.9998847516761723,0,0,1
301,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8854055574341162,0.45976505139500734,0.055957766225919664,['MAPK1'],0.9998847516761723,0,0,1
302,miRNA targets in ECM and membrane receptors WP2911,0.8854055574341162,0.45976505139500734,0.055957766225919664,['COL4A1'],0.9998847516761723,0,0,1
303,Purinergic signaling WP4900,0.8854055574341162,0.45976505139500734,0.055957766225919664,['P2RX6'],0.9998847516761723,0,0,1
304,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8858684384931304,0.5302662069745097,0.06426127998370182,"['DCLRE1C', 'BAX']",0.9998847516761723,0,0,2
305,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8858684384931304,0.5302662069745097,0.06426127998370182,"['MAPK1', 'HRAS']",0.9998847516761723,0,0,2
306,IL-5 signaling pathway WP127,0.8858684384931304,0.5302662069745097,0.06426127998370182,"['RPS6', 'MAPK1']",0.9998847516761723,0,0,2
307,Oncostatin M Signaling Pathway WP2374,0.8869817001552259,0.5742647058823529,0.06887209912396956,"['RPS6', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,3
308,Proximal tubule transport WP4917,0.8869817001552259,0.5742647058823529,0.06887209912396956,"['SLC7A9', 'SLC6A20', 'ATP6V1F']",0.9998847516761723,0,0,3
309,Regulatory circuits of the STAT3 signaling pathway WP4538,0.892619222834268,0.5990338164251208,0.06804736093734166,"['PTPRD', 'CSF3R', 'MAPK1', 'F2RL2']",0.9998847516761723,0,0,4
310,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8974828761541538,0.5105722916156421,0.055224131300620094,"['PMVK', 'ELOVL3']",0.9998847516761723,0,0,2
311,Fatty acid beta-oxidation WP143,0.8999280943316709,0.4309838472834068,0.04544311530067036,['CPT1B'],0.9998847516761723,0,0,1
312,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.8999280943316709,0.4309838472834068,0.04544311530067036,['MAPK1'],0.9998847516761723,0,0,1
313,PDGFR-beta pathway WP3972,0.8999280943316709,0.4309838472834068,0.04544311530067036,['HRAS'],0.9998847516761723,0,0,1
314,RAS and bradykinin pathways in COVID-19 WP4969,0.8999280943316709,0.4309838472834068,0.04544311530067036,['MAPK1'],0.9998847516761723,0,0,1
315,Striated Muscle Contraction Pathway WP383,0.8999280943316709,0.4309838472834068,0.04544311530067036,['TPM2'],0.9998847516761723,0,0,1
316,TLR4 Signaling and Tolerance WP3851,0.8999280943316709,0.4309838472834068,0.04544311530067036,['IKBKE'],0.9998847516761723,0,0,1
317,Apoptosis WP254,0.9013117446610613,0.5862257918056143,0.06091125315471872,"['TRADD', 'CYCS', 'BAX', 'NFKBIB']",0.9998847516761723,0,0,4
318,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9037136463822646,0.6633174765482595,0.067156073257951,"['NTRK2', 'SHC3', 'NCF2', 'RPS6', 'MAPK1', 'FRS2', 'EIF2S2', 'HRAS']",0.9998847516761723,0,0,8
319,Metabolic reprogramming in colon cancer WP4290,0.9079880191167966,0.4922850844966936,0.0475173723975273,"['IDH2', 'SLC1A5']",0.9998847516761723,0,0,2
320,Vitamin A and carotenoid metabolism WP716,0.9079880191167966,0.4922850844966936,0.0475173723975273,"['RBP7', 'MAPK1']",0.9998847516761723,0,0,2
321,7-oxo-C and 7beta-HC pathways WP5064,0.9126113371406605,0.40558866718493564,0.03708913178498625,['HSD11B2'],0.9998847516761723,0,0,1
322,Canonical and non-canonical Notch signaling WP3845,0.9126113371406605,0.40558866718493564,0.03708913178498625,['DLL3'],0.9998847516761723,0,0,1
323,IL1 and megakaryocytes in obesity WP2865,0.9126113371406605,0.40558866718493564,0.03708913178498625,['IL18'],0.9998847516761723,0,0,1
324,Pregnane X receptor pathway WP2876,0.9126113371406605,0.40558866718493564,0.03708913178498625,['PSMC5'],0.9998847516761723,0,0,1
325,Type II interferon signaling (IFNG) WP619,0.9126113371406605,0.40558866718493564,0.03708913178498625,['HLA-B'],0.9998847516761723,0,0,1
326,Glucocorticoid Receptor Pathway WP2880,0.9147538193919167,0.529920814479638,0.04721610341491646,"['GPR153', 'ALOX5AP', 'TNFAIP3']",0.9998847516761723,0,0,3
327,Prader-Willi and Angelman Syndrome WP3998,0.9147538193919167,0.529920814479638,0.04721610341491646,"['POMC', 'FEZ1', 'GNRH1']",0.9998847516761723,0,0,3
328,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9236880842373183,0.38301517376407246,0.03040406450339712,['ALOX5'],0.9998847516761723,0,0,1
329,Lipid Metabolism Pathway WP3965,0.9236880842373183,0.38301517376407246,0.03040406450339712,['ACACA'],0.9998847516761723,0,0,1
330,Oxidative Stress WP408,0.9236880842373183,0.38301517376407246,0.03040406450339712,['NOX1'],0.9998847516761723,0,0,1
331,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9260423694035089,0.45936811168258634,0.03529568211800202,"['DBI', 'ACACA']",0.9998847516761723,0,0,2
332,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9260423694035089,0.45936811168258634,0.03529568211800202,"['RPS6', 'MAPK1']",0.9998847516761723,0,0,2
333,Allograft Rejection WP2328,0.9296533101960063,0.5039634146341463,0.03676087905783863,"['HLA-B', 'HLA-DOA', 'HLA-DRB1']",0.9998847516761723,0,0,3
334,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9296533101960063,0.5039634146341463,0.03676087905783863,"['IFI27L2', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,3
335,Monoamine Transport WP727,0.9333616878736313,0.36281783754540536,0.02502082224958836,['TNFRSF11B'],0.9998847516761723,0,0,1
336,Phosphoinositides metabolism WP4971,0.9333616878736313,0.36281783754540536,0.02502082224958836,['SBF2'],0.9998847516761723,0,0,1
337,Resistin as a regulator of inflammation WP4481,0.9333616878736313,0.36281783754540536,0.02502082224958836,['MAPK1'],0.9998847516761723,0,0,1
338,Phosphodiesterases in neuronal function WP4222,0.9337622412177606,0.4445023820246024,0.03046327416488143,"['PDE6G', 'DRD1']",0.9998847516761723,0,0,2
339,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9337622412177606,0.4445023820246024,0.03046327416488143,"['ZAP70', 'CD4']",0.9998847516761723,0,0,2
340,Insulin Signaling WP481,0.9358423516239363,0.6182014179692359,0.04099185073727844,"['RPS6KA6', 'XBP1', 'SHC3', 'RHOJ', 'GRB10', 'MAPK1', 'HRAS', 'MAP4K3']",0.9998847516761723,0,0,8
341,DNA damage response WP707,0.9361688969564208,0.4919117647058823,0.03244619172706693,"['GADD45A', 'CYCS', 'BAX']",0.9998847516761723,0,0,3
342,ESC Pluripotency Pathways WP3931,0.938059763454538,0.555014489999525,0.03548852467126579,"['FGF17', 'FZD9', 'MAPK1', 'BRAF', 'HRAS']",0.9998847516761723,0,0,5
343,Fragile X Syndrome  WP4549,0.938059763454538,0.555014489999525,0.03548852467126579,"['NTRK2', 'DLG4', 'NF1', 'MAPK1', 'BRAF']",0.9998847516761723,0,0,5
344,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9410471292851877,0.5733235077376566,0.03483631530951792,"['RPS6KA6', 'SHC3', 'DIO2', 'MAPK1', 'HRAS', 'MAP4K3']",0.9998847516761723,0,0,6
345,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9418097762585007,0.344640234948605,0.020661857865706915,['HRAS'],0.9998847516761723,0,0,1
346,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.9418097762585007,0.344640234948605,0.020661857865706915,['SBF2'],0.9998847516761723,0,0,1
347,Wnt signaling in kidney disease WP4150,0.9418097762585007,0.344640234948605,0.020661857865706915,['FZD9'],0.9998847516761723,0,0,1
348,G1 to S cell cycle control WP45,0.9421229642791873,0.4804206566347469,0.0286424285751524,"['GADD45A', 'E2F3', 'MNAT1']",0.9998847516761723,0,0,3
349,Genes related to primary cilium development (based on CRISPR) WP4536,0.9421229642791873,0.4804206566347469,0.0286424285751524,"['DYNLT1', 'TTC21B', 'DYNLL1']",0.9998847516761723,0,0,3
350,miRNA regulation of DNA damage response WP1530,0.9421229642791873,0.4804206566347469,0.0286424285751524,"['GADD45A', 'CYCS', 'BAX']",0.9998847516761723,0,0,3
351,Glioblastoma signaling pathways WP2261,0.9465424304234296,0.5098520153707792,0.02801100489475617,"['NF1', 'MAPK1', 'BRAF', 'HRAS']",0.9998847516761723,0,0,4
352,Toll-like Receptor Signaling Pathway WP75,0.9465424304234296,0.5098520153707792,0.02801100489475617,"['MAPK1', 'CD14', 'IKBKE', 'NFKBIB']",0.9998847516761723,0,0,4
353,Prostaglandin Synthesis and Regulation WP98,0.946969117953396,0.4174737826464498,0.022747644080835648,"['HSD11B2', 'S100A6']",0.9998847516761723,0,0,2
354,Metapathway biotransformation Phase I and II WP702,0.9484665671464633,0.5799747663219249,0.03068573316710647,"['GSTZ1', 'GSTK1', 'CYP2C8', 'GPX4', 'GSTO1', 'GSTP1', 'CHST10']",0.9998847516761723,0,0,7
355,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9491875055134485,0.32819383259911894,0.017114953160296275,['IKBKE'],0.9998847516761723,0,0,1
356,miRNA regulation of prostate cancer signaling pathways WP3981,0.9491875055134485,0.32819383259911894,0.017114953160296275,['MAPK1'],0.9998847516761723,0,0,1
357,White fat cell differentiation WP4149,0.9491875055134485,0.32819383259911894,0.017114953160296275,['DDIT3'],0.9998847516761723,0,0,1
358,Notch Signaling Pathway Netpath WP61,0.9525916416530776,0.4051519211652332,0.01967780943826723,"['PSENEN', 'DLL3']",0.9998847516761723,0,0,2
359,Pathogenic Escherichia coli infection WP2272,0.9525916416530776,0.4051519211652332,0.01967780943826723,"['ARPC1B', 'CD14']",0.9998847516761723,0,0,2
360,ATM Signaling Pathway WP2516,0.9556304008545325,0.31324255773594983,0.014216216111800704,['GADD45A'],0.9998847516761723,0,0,1
361,Genes controlling nephrogenesis WP4823,0.9556304008545325,0.31324255773594983,0.014216216111800704,['PAX2'],0.9998847516761723,0,0,1
362,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9556304008545325,0.31324255773594983,0.014216216111800704,['RAB13'],0.9998847516761723,0,0,1
363,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.9556304008545325,0.31324255773594983,0.014216216111800704,['IKBKE'],0.9998847516761723,0,0,1
364,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9570318203046361,0.4489450127877238,0.0197170535096914,"['MAPK1', 'IKBKE', 'HDAC9']",0.9998847516761723,0,0,3
365,Folate Metabolism WP176,0.9576416063910561,0.3935341660543718,0.017032818691186242,"['AHCY', 'GPX4']",0.9998847516761723,0,0,2
366,IL-1 signaling pathway WP195,0.9576416063910561,0.3935341660543718,0.017032818691186242,"['MAPK1', 'NFKBIB']",0.9998847516761723,0,0,2
367,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9576416063910561,0.3935341660543718,0.017032818691186242,"['MAPK1', 'NFKBIB']",0.9998847516761723,0,0,2
368,Ebola Virus Pathway on Host WP4217,0.9593369977882623,0.51332073066186,0.021309411841140744,"['HLA-B', 'MAPK1', 'HLA-DOA', 'IKBKE', 'HLA-DRB1']",0.9998847516761723,0,0,5
369,ATM Signaling Network in Development and Disease  WP3878,0.9612568389568434,0.2995913937304476,0.011837947538941568,['DCLRE1C'],0.9998847516761723,0,0,1
370,G13 Signaling Pathway WP524,0.9612568389568434,0.2995913937304476,0.011837947538941568,['ARHGDIB'],0.9998847516761723,0,0,1
371,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9612568389568434,0.2995913937304476,0.011837947538941568,['LAMA5'],0.9998847516761723,0,0,1
372,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9612568389568434,0.2995913937304476,0.011837947538941568,['BAX'],0.9998847516761723,0,0,1
373,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9612568389568434,0.2995913937304476,0.011837947538941568,['STAR'],0.9998847516761723,0,0,1
374,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9619750891311989,0.5530719153697488,0.02144078603298069,"['COL4A1', 'CTDSP1', 'FZD9', 'MAPK1', 'WNT9A', 'HRAS', 'DLL3']",0.9998847516761723,0,0,7
375,Energy Metabolism WP1541,0.9661702160952872,0.28707782672540383,0.009879856081739576,['UCP3'],0.9998847516761723,0,0,1
376,Hedgehog Signaling Pathway WP4249,0.9661702160952872,0.28707782672540383,0.009879856081739576,['CSNK1G1'],0.9998847516761723,0,0,1
377,Rett syndrome causing genes WP4312,0.9661702160952872,0.28707782672540383,0.009879856081739576,['BRAF'],0.9998847516761723,0,0,1
378,AMP-activated protein kinase (AMPK) signaling WP1403,0.9698805198997894,0.36234966549363856,0.011081518943197075,"['CPT1B', 'ACACA']",0.9998847516761723,0,0,2
379,IL-6 signaling pathway WP364,0.9704608429071554,0.2755653450807636,0.008262613178597472,['MAPK1'],0.9998847516761723,0,0,1
380,Neovascularisation processes WP4331,0.9704608429071554,0.2755653450807636,0.008262613178597472,['MAPK1'],0.9998847516761723,0,0,1
381,Tryptophan metabolism WP465,0.9704608429071554,0.2755653450807636,0.008262613178597472,['HSD17B10'],0.9998847516761723,0,0,1
382,Head and Neck Squamous Cell Carcinoma WP4674,0.9713667946512914,0.4128529411764706,0.011993845553584907,"['RPS6', 'CSMD3', 'HRAS']",0.9998847516761723,0,0,3
383,Cardiac Progenitor Differentiation WP2406,0.9742075993242281,0.2649384389472495,0.006923068478081396,['MESP1'],0.9998847516761723,0,0,1
384,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9742075993242281,0.2649384389472495,0.006923068478081396,['MAP1LC3A'],0.9998847516761723,0,0,1
385,Integrated Cancer Pathway WP1971,0.9742075993242281,0.2649384389472495,0.006923068478081396,['BAX'],0.9998847516761723,0,0,1
386,Retinoblastoma gene in cancer WP2446,0.9767053283983556,0.3968891402714932,0.009354788574671334,"['H2AFZ', 'E2F3', 'SKP2']",0.9998847516761723,0,0,3
387,Pathways affected in adenoid cystic carcinoma WP3651,0.9786731107052516,0.33572875038081756,0.007237503903279385,"['SETD2', 'HRAS']",0.9998847516761723,0,0,2
388,G Protein Signaling Pathways WP35,0.9790054022130297,0.38935904550499445,0.008261466317461613,"['GNG10', 'GNG3', 'HRAS']",0.9998847516761723,0,0,3
389,Development of ureteric collection system WP5053,0.9803363599943762,0.2459618208516887,0.004884689043102971,['PAX2'],0.9998847516761723,0,0,1
390,One-carbon metabolism and related pathways WP3940,0.9803363599943762,0.2459618208516887,0.004884689043102971,['GPX4'],0.9998847516761723,0,0,1
391,Oxidation by Cytochrome P450 WP43,0.9803363599943762,0.2459618208516887,0.004884689043102971,['CYP2C8'],0.9998847516761723,0,0,1
392,Nuclear Receptors Meta-Pathway WP2882,0.981528543139741,0.6046866817943795,0.011273890088864065,"['SERPINA1', 'GSTP1', 'AIP', 'TNFAIP3', 'DBI', 'TXN', 'SLC6A20', 'SLC5A3', 'PSMC5', 'GPR153', 'FTH1', 'ALOX5AP', 'ME1', 'BAX', 'FTL']",0.9998847516761723,0,0,15
393,Regulation of toll-like receptor signaling pathway WP1449,0.9832408397331373,0.4461775338063998,0.007540928608358749,"['CUEDC2', 'TNFAIP3', 'MAPK1', 'CD14', 'IKBKE']",0.9998847516761723,0,0,5
394,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9850094795068277,0.22951541850220264,0.003466604092335456,['BAX'],0.9998847516761723,0,0,1
395,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9850094795068277,0.22951541850220264,0.003466604092335456,['TRADD'],0.9998847516761723,0,0,1
396,Hepatitis B infection WP4666,0.9855771922046987,0.46296771629420486,0.006725915118870832,"['CYCS', 'MAPK1', 'BAX', 'BRAF', 'IKBKE', 'HRAS']",0.9998847516761723,0,0,6
397,DNA damage response (only ATM dependent) WP710,0.9857401438513386,0.40427650088733064,0.005806423226369608,"['RAC3', 'MAPK1', 'BAX', 'HRAS']",0.9998847516761723,0,0,4
398,AGE/RAGE pathway WP2324,0.9866171311883521,0.30575557188341906,0.004119514064179935,"['MAPK1', 'CYCS']",0.9998847516761723,0,0,2
399,Spinal Cord Injury WP2431,0.9872841751983995,0.42930780559646536,0.005494007764694883,"['COL4A1', 'GADD45A', 'APEX1', 'TNFSF13', 'MAPK1']",0.9998847516761723,0,0,5
400,Glycolysis and Gluconeogenesis WP534,0.9885724914864248,0.21512481644640236,0.0024724949613962625,['ALDOA'],0.9998847516761723,0,0,1
401,Cell cycle WP179,0.9893995030886161,0.3870700287079356,0.00412503719969625,"['GADD45A', 'E2F3', 'SKP2', 'ANAPC11']",0.9998847516761723,0,0,4
402,Gastrin signaling pathway WP4659,0.9893995030886161,0.3870700287079356,0.00412503719969625,"['RPS6', 'MAPK1', 'HRAS', 'PTK2']",0.9998847516761723,0,0,4
403,Osteoblast differentiation WP4787,0.9893995030886161,0.3870700287079356,0.00412503719969625,"['FZD9', 'MAPK1', 'WNT9A', 'DLL3']",0.9998847516761723,0,0,4
404,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9894218074112995,0.29268216424093674,0.003112540002918373,"['RYK', 'FZD9']",0.9998847516761723,0,0,2
405,"GPCRs, Class A Rhodopsin-like WP455",0.9897896203233176,0.5017653204597039,0.005149548822186631,"['CHRM3', 'GPR65', 'CHRM5', 'OR7A5', 'GPR37L1', 'OR6A2', 'DRD1', 'F2RL2', 'HCRTR1']",0.9998847516761723,0,0,9
406,IL-4 signaling pathway WP395,0.9912889541981639,0.2024272263971668,0.001771078060244563,['MAPK1'],0.9998847516761723,0,0,1
407,Lung fibrosis WP3624,0.9912889541981639,0.2024272263971668,0.001771078060244563,['SERPINA1'],0.9998847516761723,0,0,1
408,TGF-beta Receptor Signaling WP560,0.9912889541981639,0.2024272263971668,0.001771078060244563,['HRAS'],0.9998847516761723,0,0,1
409,Calcium Regulation in the Cardiac Cell WP536,0.992257361708026,0.4288872512896094,0.0033336411623066946,"['CHRM3', 'PKIB', 'GNG3', 'CHRM5', 'ATP1A4', 'RGS6']",0.9998847516761723,0,0,6
410,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9925844453981154,0.2750330639235856,0.002047122392751136,"['RYK', 'FZD9']",0.9998847516761723,0,0,2
411,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9933598876918865,0.1911404796867352,0.0012734267947110698,['HRAS'],0.9998847516761723,0,0,1
412,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9940301175632574,0.3899451064399518,0.002334902945614444,"['NTRK2', 'SST', 'AVP', 'ALDOA', 'HDAC9']",0.9998847516761723,0,0,5
413,Pathways Regulating Hippo Signaling WP4540,0.9941799885465177,0.3170701357466063,0.001850742732924516,"['NTRK2', 'CDH13', 'CDH8']",0.9998847516761723,0,0,3
414,Endoderm differentiation WP2853,0.9942102828048294,0.3566793765469262,0.0020710739880488577,"['TNRC6C', 'ACACA', 'AHDC1', 'NME1']",0.9998847516761723,0,0,4
415,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9947991608409342,0.5427794263105836,0.002830274793334975,"['LAMA5', 'CSF3R', 'CAB39L', 'RPS6', 'ITGB2', 'VEGFB', 'ITGAE', 'PTK2', 'ACACA', 'FGF17', 'GNG10', 'GNG3', 'COL4A1', 'MAPK1', 'HRAS']",0.9998847516761723,0,0,15
416,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9949386049685728,0.18104181157740165,0.0009186509193219547,['TNFRSF11B'],0.9998847516761723,0,0,1
417,"GPCRs, Other WP117",0.9954008953626754,0.2545513919503633,0.0011734088753320145,"['CHRM3', 'ADGRL2']",0.9998847516761723,0,0,2
418,Myometrial relaxation and contraction pathways WP289,0.9955308302162545,0.40339850015171874,0.0018068970668142208,"['PKIB', 'GNG3', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9998847516761723,0,0,6
419,Mesodermal commitment pathway WP2857,0.9955343880917653,0.37696839243230995,0.001687164463153208,"['EXT2', 'SETD2', 'RPL38', 'ACACA', 'AHDC1']",0.9998847516761723,0,0,5
420,Peptide GPCRs WP24,0.9955810906555044,0.17638088783463232,0.0007811383170551751,['HCRTR1'],0.9998847516761723,0,0,1
421,Ectoderm Differentiation WP2858,0.9961617195505336,0.3389202300166244,0.0013033738532211934,"['CTNND2', 'TNFRSF11B', 'CDH8', 'LY6E']",0.9998847516761723,0,0,4
422,Complement and Coagulation Cascades WP558,0.99663175961313,0.16774112675047456,0.0005659460948667292,['SERPINA1'],0.9998847516761723,0,0,1
423,Neural Crest Differentiation WP2064,0.9967945716586862,0.24107660775745388,0.0007739949473864207,"['HDAC9', 'DLL3']",0.9998847516761723,0,0,2
424,Joubert Syndrome WP4656,0.9974325938737137,0.15990506437181984,0.0004110691587203582,['PDE6G'],0.9998847516761723,0,0,1
425,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9977584712037464,0.15625417167267389,0.00035064135867017836,['CTSV'],0.9998847516761723,0,0,1
426,Endochondral Ossification WP474,0.9977584712037464,0.15625417167267389,0.00035064135867017836,['CTSV'],0.9998847516761723,0,0,1
427,Ciliopathies WP4803,0.9978960671319467,0.3737388624639914,0.0007871498226667967,"['DNAAF3', 'TBC1D32', 'TTC21B', 'CCNQ', 'CCDC28B', 'CNGB1']",0.9998847516761723,0,0,6
428,Wnt signaling WP428,0.9986299263763188,0.2145481263776635,0.0002941482774021613,"['RYK', 'FZD9']",0.9998847516761723,0,0,2
429,Adipogenesis WP236,0.9989095710770666,0.2572058823529412,0.0002806177579465738,"['GADD45A', 'CELF1', 'DDIT3']",0.9998847516761723,0,0,3
430,PI3K-Akt signaling pathway WP4172,0.9992248277125433,0.46589885913684936,0.00036129193420659546,"['LAMA5', 'NTRK2', 'CSF3R', 'RPS6', 'VEGFB', 'PTK2', 'FGF17', 'GNG10', 'GNG3', 'COL4A1', 'MAPK1', 'COL9A3', 'PIK3AP1', 'HRAS']",0.9998847516761723,0,0,14
431,Wnt signaling pathway and pluripotency WP399,0.999743027421194,0.11439060205580029,2.939902553495044e-05,['FZD9'],0.9998847516761723,0,0,1
432,Male infertility WP4673,0.9998847516761723,0.1039247096515819,1.1977838817806946e-05,['PEX10'],0.9998847516761723,0,0,1
